Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma [Phase 2]
Phase 2 clinical trial update for 6MW3211 injection in relapsed/refractory lymphoma.
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma [Phase 2]
Phase 2 clinical trial update for Mecapegfilgrastim (PEG-G-CSF) as prophylaxis for chemotherapy-induced neutropenia in lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies [Phase 1]
Phase 1 trial update evaluating zanubrutinib with tislelizumab in B-cell malignancies has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis [Phase 2]
Phase 2 clinical trial update on post-transplant cyclophosphamide for graft-versus-host disease prophylaxis completed; results posted in 202…
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy [Phase 2]
Phase 2 clinical trial of a monoclonal antibody therapy for lymphoproliferative disorder associated with immunosuppression.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) [Phase 3]
Phase 3 trial assessing combination chemotherapy in children with anaplastic large cell lymphoma (ALCL 99) has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 trial investigating dasatinib combined with ifosfamide, carboplatin, and etoposide in young patients with metastatic or recu…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia [Phase 4]
Phase 4 clinical trial evaluating rasburicase for prevention and treatment of hyperuricemia in pediatric patients with non-Hodgkin's lymphom…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma [Phase 2]
Phase 2 trial evaluating R-FND chemotherapy plus Zevalin for high-risk follicular lymphoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Effect of Vitamin C in Autologous Stem Cell Transplantations [Phase 2]
Phase 2 trial update evaluating the effect of Vitamin C in autologous stem cell transplantations for myeloma and lymphoma is completed.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL [Phase 1, Phase 2]
Phase 1/2 trial evaluating sintilimab combined with chidamide for refractory and relapsed extranodal NK/T-cell lymphoma (ENKTL) has complete…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma [Phase 2]
A Phase 2 trial evaluating camrelizumab in combination with CD30 CAR-T for relapsed/refractory CD30+ lymphoma.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma [Phase 2]
Phase 2 trial update for GOAL: GA101 plus pixantrone in relapsed aggressive lymphoma (non-Hodgkin lymphoma).
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT [Phase 1, Phase 2]
This clinical trial evaluates the safety and efficacy of γδ T cell therapy after allogeneic hematopoietic stem cell transplantation in hemat…
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase [Phase 3]
Phase 3 trial evaluating safety and effectiveness of apixaban to prevent blood clots in children with leukemia and a central venous catheter…
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy. [Phase 2]
Phase 2 trial evaluating ivabradine for cardiac autonomic dysfunction related to thoracic radiation therapy; study terminated with results p…
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT) [Phase 2]
Phase 2 trial evaluating whether statins prevent doxorubicin-induced cardiovascular toxicity in patients with breast cancer or lymphoma.
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects [Phase 2]
Phase 2 clinical trial update evaluating Chi-BEAC with auto-HSCT for aggressive lymphomas, reporting on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma [Phase 1, Phase 2]
Phase I/II trial evaluating epacadostat with intralesional SD101 and radiotherapy in lymphoma and advanced solid tumors has completed with r…
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma [Phase 1, Phase 2]
A multi-phase (Phase 1/2) clinical trial evaluating IM19 CAR-T cells for relapsed/refractory mantle cell lymphoma is ongoing; status current…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas [Phase 1]
Phase 1 trial update for Sym023 (anti-TIM-3) in patients with advanced solid tumors, metastatic cancer, or lymphomas; results posted after c…
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: Nonmyeloablative Haploidentical Transplant Followed by MLN9708 [Phase 2]
Phase 2 trial evaluating nonmyeloablative haploidentical transplant followed by MLN9708 (ixazomib) in various hematologic malignancies compl…
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A) [Phase 2]
Phase 2 MATCH subprotocol evaluates binimetinib as a targeted treatment for cancers with NRAS alterations; results were posted in 2021 and t…
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial update on a radiolabeled monoclonal antibody for detection and staging in lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating monoclonal antibodies for detecting residual disease in patients treated for non-Hodgkin's lymphoma.